CONMED CORP's ticker is and the CUSIP is 207410AF8. A total of 44 filers reported holding CONMED CORP in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $2,486,736 | +7.3% | 2,016,000 | -1.0% | 0.01% | +9.1% |
| Q4 2022 | $2,318,106 | -4.7% | 2,037,000 | -7.8% | 0.01% | 0.0% |
| Q3 2022 | $2,432,000 | -13.9% | 2,209,000 | -5.1% | 0.01% | -8.3% |
| Q2 2022 | $2,824,000 | -92.7% | 2,328,000 | -89.7% | 0.01% | -91.8% |
| Q1 2022 | $38,817,000 | +1.4% | 22,651,000 | -1.4% | 0.15% | +2.1% |
| Q4 2021 | $38,271,000 | +7.0% | 22,961,000 | -0.4% | 0.14% | -8.3% |
| Q3 2021 | $35,765,000 | -4.2% | 23,047,000 | -0.2% | 0.16% | -8.8% |
| Q2 2021 | $37,345,000 | +3.7% | 23,085,000 | +0.5% | 0.17% | -12.8% |
| Q1 2021 | $36,014,000 | +11.6% | 22,981,000 | -0.1% | 0.20% | +4.8% |
| Q4 2020 | $32,262,000 | +26.0% | 23,007,000 | +1.1% | 0.19% | +13.3% |
| Q3 2020 | $25,610,000 | +13.1% | 22,766,000 | +5.7% | 0.16% | +3.1% |
| Q2 2020 | $22,653,000 | +19.5% | 21,531,000 | +6.2% | 0.16% | +7.4% |
| Q1 2020 | $18,959,000 | – | 20,269,000 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABSOLUTE INVESTMENT ADVISERS, LLC | 4,035,000 | $4,888,000 | 0.98% |
| III Capital Management | 3,669,000 | $4,453,000 | 0.41% |
| SHENKMAN CAPITAL MANAGEMENT INC | 3,972,000 | $4,789,000 | 0.29% |
| MACKAY SHIELDS LLC | 6,783,000 | $8,195,000 | 0.20% |
| Warberg Asset Management LLC | 722,000 | $875,000 | 0.19% |
| ZAZOVE ASSOCIATES LLC | 1,628,000 | $1,967,000 | 0.19% |
| PALISADE CAPITAL MANAGEMENT, LP | 3,564,000 | $4,312,000 | 0.12% |
| Teton Advisors, Inc. | 350,000 | $423,000 | 0.09% |
| Calamos Wealth Management LLC | 823,000 | $998,000 | 0.09% |
| WESTWOOD HOLDINGS GROUP INC | 4,310,000 | $5,263,000 | 0.06% |